---
title: "TMSP: Notification of Drug Re-registration Approval from Subsidiary"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/249731979.md"
description: "TMSP announced that its subsidiary has received the drug re-registration approval notice issued by the Anhui Provincial Drug Administration, covering various drugs, including kidney-tonifying tablets and cold relief tablets. The approval is valid until 2030 and is applicable to multiple symptoms. This move will positively impact the company's production, sales, and promotion"
datetime: "2025-07-23T09:30:13.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/249731979.md)
  - [en](https://longbridge.com/en/news/249731979.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/249731979.md)
---

# TMSP: Notification of Drug Re-registration Approval from Subsidiary

TMSP announced that its subsidiary Huangshan TMSP Co., Ltd. and Huangshan TMSP Mint Pharmaceutical Co., Ltd. have received the "Drug Re-registration Approval Notice" issued by the Anhui Provincial Drug Administration. The approved drugs include Kidney Strengthening Tablets, Andrographis Paniculata Capsules, Cold Relief Tablets, Cold and Fever Granules, Lion's Mane Mushroom Tablets, Muscle and Bone Grass Tablets, Antelope Detox Tablets, Antelope Cold Tablets, Brain Nourishing Tablets, Mulberry and Chrysanthemum Cold Tablets, Polygonum Multiflorum Longevity Tablets, and Blood Nourishing and Calming Tablets. The approval notices for these drugs are valid until 2030 and are applicable for symptoms such as lower back pain, weakness in the legs, dizziness, and tinnitus. This move will have a positive impact on the company's subsequent production, sales, and promotion

### Related Stocks

- [600671.CN](https://longbridge.com/en/quote/600671.CN.md)

## Related News & Research

- [Desert Control subscription rights trading ends as rights issue deadline nears](https://longbridge.com/en/news/294914623.md)
- [Flight 13 of Starship was (mostly) a triumph for SpaceX](https://longbridge.com/en/news/294608682.md)
- [ASPO: Strong Q2 profit growth and a board-approved demerger set the stage for focused future growth](https://longbridge.com/en/news/294689293.md)
- [NEXT Biometrics announces extraordinary general meeting](https://longbridge.com/en/news/294972538.md)
- [Norsk Titanium registers 12,055,995-share issue, lifting share capital to NOK 104.12 million](https://longbridge.com/en/news/294825194.md)